Elin Haf Davies
Chief Executive Officer
Elin Haf has 20+ years experience of drug development in paediatrics and rare disease, clinically, academically and as a regulator at the European Medicine Agency.
Elin Haf now serves as the Chair of Metabolic Support UK and the CEO of Aparito – a medtech company supporting centralised clinical trials and the development of digital biomarkers.
Elin Haf is a shareholder for Aparito.